Project Grant RF1AG075717

Award Date 8/1/22
Completion Date 7/31/25
Dollars Obligated $4.6M
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92093, USA
Similar Awards
This Project Grant award, valued at $305,014, was provided by the National Institute on Aging (NIA) under the Aging Research Federal Grant Program (CFDA 93.866). The project aims to quantify Alzheimer's disease (AD)-specific myelin degeneration in the hippocampus and surrounding brain regions, and determine the spatial relationship between myelin loss and AD pathologies like amyloid and tau. The research will leverage novel X-ray imaging techniques, histological analysis, and molecular profiling...
This $4.46 million project grant from the National Institute on Aging, part of the Department of Health and Human Services, supports research under the Aging Research program (CFDA 93.866) to develop a new in vivo magnetic resonance imaging biomarker for early detection of Alzheimer's disease neurodegeneration. Specifically, the awardee, Washington University, will utilize quantitative gradient recalled echo MRI techniques to identify two types of hippocampal tissue in preclinical and mild...
The National Institute on Aging (NIA) awarded a $433,125 project grant under CFDA Program 93.866 (Aging Research) to the Regents of the University of California at Riverside (UC Riverside). The award will fund a 2-year research project to use novel magnetic resonance imaging (MRI) and spectroscopy (MRS) techniques to characterize age-related neuroinflammation and its relationship to memory performance. Key objectives include: Testing whether older age is associated with higher MRS-derived...
The National Institute on Aging (NIA) awarded New York University a $254,250 Project Grant under the Aging Research federal grant program (CFDA 93.866) to develop a biologically-relevant multi-scale model of brain aging using advanced diffusion MRI (dMRI) techniques. The project aims to bridge the gap between microscopic and macroscopic brain changes to disentangle the roles of neuroinflammation and neurodegeneration in Alzheimer's disease and related dementias. The researchers will create a...
This $467,593 Project Grant award from the National Institute on Aging's Aging Research Federal Grant Program (CFDA 93.866) aims to characterize the molecular and cellular diversity of astrocytes, a key cell type in the brain, in Alzheimer's disease (AD) compared to healthy controls. The project will employ advanced multimodal imaging techniques including mass spectrometry imaging (MSI) and multiplexed immunofluorescence (MxIF) to map the spatial relationships between different cell phenotypes...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $2,288,327 to the University of California, San Diego (UCSD) to investigate early determinants of Alzheimer's disease (AD) using age-equivalent neurons derived from mild cognitive impairment (MCI) patients. The goal is to better understand the early trajectory of MCI and AD by integrating polygenic risk scores with multi-omic characterization of patient-derived induced neurons. This will...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $800,700 in funding to The Regents of the University of California, San Francisco (UCSF) to conduct a longitudinal, multimodal imaging study. The goal is to elucidate the role of neuronal dysfunction and hyperexcitability in the early biological progression of Alzheimer's disease. The study will identify the earliest manifestations of neural circuit hyperexcitability that predict the...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $148,568 to Duke University to conduct research on brain connectivity in healthy aging and Alzheimer's disease using high-resolution diffusion imaging. The primary objectives are to examine how standard and high-resolution diffusion-weighted imaging measures relate to age-related cognitive differences and functional connectivity in healthy adults (ages 18-80) as well as identify any additional...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $866,723 to The Johns Hopkins University to conduct a multi-scale MRI-based study investigating the relationship between Alzheimer's disease pathology, regional brain atrophy, and molecular signatures in the entorhinal cortex. The research aims to integrate high-field post-mortem MRI imaging, histological analysis, and spatial transcriptomic profiling to link neuronal transcriptional changes...
This $287,118 Project Grant was awarded on September 1, 2023 by the National Institute on Aging (NIA) under the Aging Research (CFDA 93.866) grant program. The grant will fund the development of techniques to use deep transfer learning and multimodal data, including brain MRIs, genetic information, and cognitive tests, to enable the early detection and forecasting of Alzheimer's disease progression. The University of Massachusetts (UMass), as the prime awardee, will create an end-to-end...

This Project Grant from the National Institutes of Health's National Institute on Aging, under the Aging Research program (CFDA 93.866), provides $4,638,424 to the University of California, San Diego from August 1, 2022 to July 31, 2025. The grant will support research developing novel quantitative magnetic resonance imaging techniques to directly image myelin and quantify myelin content and properties in the brain. Specifically, the researchers will use ultra-short echo time sequences with echo times less than 1 millisecond to detect signal from myelin and map its T1 and T2 values. Developing non-invasive imaging methods to accurately evaluate myelin could provide critical insights into the pathogenesis and diagnosis of Alzheimer's disease, as well as monitoring treatment effectiveness, given myelin's indispensable role in cognitive functions.

Generated 1/6/24, 2:34 PM